# Peking Medicine Manufactory · 66-41 · HONG KONG SAR — FDA import alert red lists: firms subject to detention without physical examination

For Peking Medicine Manufactory · 66-41 · HONG KONG SAR, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is HONG KONG SAR; product is Armadillo Trade Mark Counter Poison Pill; product code is 61 X B A 99 Anti-Histaminic N.E.C., Human - Non/Rx Combination Ingredient, Prompt Release Tablets; date published is 04/04/2011; address is Unit B, 7/F, Phase 1 , Leader Industry Centre , Tsuen Wan, New Territories HONG KONG SAR, verified against its source on 2026-09-16.

- **Firm:** Peking Medicine Manufactory _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** HONG KONG SAR _(verified: appears in the quote below)_
- **Address:** Unit B, 7/F, Phase 1 , Leader Industry Centre , Tsuen Wan, New Territories HONG KONG SAR _(verified: appears in the quote below)_
- **Date published:** 04/04/2011 _(verified: appears in the quote below)_
- **Product code:** 61 X B A 99 Anti-Histaminic N.E.C., Human - Non/Rx Combination Ingredient, Prompt Release Tablets _(verified: appears in the quote below)_
- **Product:** Armadillo Trade Mark Counter Poison Pill _(verified: appears in the quote below)_
- **FDA notes:** Hong Kong _(verified: appears in the quote below)_

## What the source says

> Peking Medicine Manufactory Date Published : 04/04/2011 Unit B, 7/F, Phase 1 , Leader Industry Centre , Tsuen Wan, New Territories HONG KONG SAR 61 X B A 99 Anti-Histaminic N.E.C., Human - Non/Rx Combination Ingredient, Prompt Release Tablets Date Published: 04/04/2011 Desc: Armadillo Trade Mark Counter Poison Pill Notes: Hong Kong

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).